Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fraser

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Entropy (Basel, Switzerland)|May 26, 2026
Effective Mode Approximation for Probabilistic Verification of Collective Hamiltonians in Large Continuous-Variable Quantum SystemsJosé R Rosas-Bustos, Jesse Van Griensven Thé, Roydon Andrew Fraser, et al.
Cell Reports|March 24, 2021
On the role of p53 in the cellular response to aneuploidyAkshay Narkar, Blake A Johnson, Pandurang Bharne, et al.
Frontline Gastroenterology|June 17, 2022
Increasing the low-risk threshold for patients with upper gastrointestinal bleeding during the COVID-19 pandemic: a prospective, multicentre feasibility studyPhilip Dunne, Victoria Livie, Aaron McGowan, et al.
Journal of Viral Hepatitis|May 18, 2021
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortalityScott A McDonald, Stephen T Barclay, Hamish A Innes, et al.
Hepatology (Baltimore, Md.)|September 11, 2012
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectivenessHamish A Innes, Sharon J Hutchinson, Stephen Barclay, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort studyHamish Innes, Scott A McDonald, Victoria Hamill, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohortHuan Wang, Hamish Innes, Sharon J Hutchinson, et al.
Gastro Hep Advances|August 12, 2024
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-makingHamish Innes, Philip Johnson, Scott A McDonald, et al.
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Frontline Gastroenterology|July 27, 2018
Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymesMichael Hugh Miller, Andrew Fraser, Gillian Leggett, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Entropy (Basel, Switzerland)|May 26, 2026
Effective Mode Approximation for Probabilistic Verification of Collective Hamiltonians in Large Continuous-Variable Quantum SystemsJosé R Rosas-Bustos, Jesse Van Griensven Thé, Roydon Andrew Fraser, et al.
Cell Reports|March 24, 2021
On the role of p53 in the cellular response to aneuploidyAkshay Narkar, Blake A Johnson, Pandurang Bharne, et al.
Frontline Gastroenterology|June 17, 2022
Increasing the low-risk threshold for patients with upper gastrointestinal bleeding during the COVID-19 pandemic: a prospective, multicentre feasibility studyPhilip Dunne, Victoria Livie, Aaron McGowan, et al.
Journal of Viral Hepatitis|May 18, 2021
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortalityScott A McDonald, Stephen T Barclay, Hamish A Innes, et al.
Hepatology (Baltimore, Md.)|September 11, 2012
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectivenessHamish A Innes, Sharon J Hutchinson, Stephen Barclay, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort studyHamish Innes, Scott A McDonald, Victoria Hamill, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohortHuan Wang, Hamish Innes, Sharon J Hutchinson, et al.
Gastro Hep Advances|August 12, 2024
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-makingHamish Innes, Philip Johnson, Scott A McDonald, et al.
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Frontline Gastroenterology|July 27, 2018
Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymesMichael Hugh Miller, Andrew Fraser, Gillian Leggett, et al.
Pageof 7